Published in Genes Brain Behav on December 27, 2013
Gut/brain axis and the microbiota. J Clin Invest (2015) 1.64
Control of brain development, function, and behavior by the microbiome. Cell Host Microbe (2015) 1.48
Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci (2014) 1.47
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol (2015) 1.25
Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res (2014) 1.10
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Molecular insights into transgenerational non-genetic inheritance of acquired behaviours. Nat Rev Genet (2015) 0.99
Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol (2015) 0.97
Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry (2015) 0.96
Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol (2016) 0.91
Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders. Microb Ecol Health Dis (2015) 0.91
Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Neurosci Lett (2016) 0.91
Friends with social benefits: host-microbe interactions as a driver of brain evolution and development? Front Cell Infect Microbiol (2014) 0.88
Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD). J Nat Sci (2015) 0.86
Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner. PLoS One (2014) 0.86
Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome. Neuropsychopharmacology (2016) 0.86
May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry. CNS Drugs (2016) 0.86
Genomics of schizophrenia: time to consider the gut microbiome? Mol Psychiatry (2014) 0.85
A novel role for maternal stress and microbial transmission in early life programming and neurodevelopment. Neurobiol Stress (2015) 0.83
Complete Genome Sequence of Bifidobacterium longum GT15: Identification and Characterization of Unique and Global Regulatory Genes. Microb Ecol (2015) 0.83
Gut microbiota in hypertension. Curr Opin Nephrol Hypertens (2015) 0.82
Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int J Neuropsychopharmacol (2016) 0.82
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain Behav Immun (2016) 0.82
Gut Microbiota: The Brain Peacekeeper. Front Microbiol (2016) 0.81
Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer's Disease (AD). J Alzheimers Dis Parkinsonism (2015) 0.80
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol (2016) 0.80
Sex differences in the gut microbiome-brain axis across the lifespan. Philos Trans R Soc Lond B Biol Sci (2016) 0.79
Gut microbiota: Microbiota and neuroimmune signalling-Metchnikoff to microglia. Nat Rev Gastroenterol Hepatol (2015) 0.79
Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish. Sci Rep (2016) 0.79
Epigenome-Microbiome crosstalk: A potential new paradigm influencing neonatal susceptibility to disease. Epigenetics (2016) 0.79
Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota. Int J Mol Sci (2016) 0.79
Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep (2015) 0.79
Microbiomes, plausible players or not in alteration of host behavior. Front Microbiol (2015) 0.79
Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model. Gut Microbes (2016) 0.78
Gastroenterology issues in schizophrenia: why the gut matters. Curr Psychiatry Rep (2015) 0.78
Stress and the commensal microbiota: importance in parturition and infant neurodevelopment. Front Psychiatry (2015) 0.78
Physical activity level is impaired and diet dependent in preterm newborn pigs. Pediatr Res (2015) 0.78
Gut Microbiome and Infant Health: Brain-Gut-Microbiota Axis and Host Genetic Factors. Yale J Biol Med (2016) 0.78
Birth by Caesarean Section and the Risk of Adult Psychosis: A Population-Based Cohort Study. Schizophr Bull (2015) 0.78
Autism spectrum disorders and intestinal microbiota. Gut Microbes (2015) 0.77
Future directions for research in autism spectrum disorders. J Clin Child Adolesc Psychol (2014) 0.77
Microbiota-gut-brain axis and the central nervous system. Oncotarget (2017) 0.76
Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. J Int Soc Sports Nutr (2016) 0.76
Neuroimmune pharmacological approaches. Curr Opin Pharmacol (2015) 0.76
Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access (2016) 0.76
Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals. Trends Neurosci (2016) 0.76
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? NPJ Parkinsons Dis (2017) 0.76
Mechanisms of the Maternal Exposome and Implications for Health Outcomes. ANS Adv Nurs Sci (2016) 0.75
The Immune Syntax Revisited: Opening New Windows on Language Evolution. Front Mol Neurosci (2016) 0.75
Gut Microbiota: A Modulator of Brain Plasticity and Cognitive Function in Ageing. Healthcare (Basel) (2015) 0.75
GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015. Microb Ecol Health Dis (2015) 0.75
Host response: A trigger for neurodegeneration? Nat Microbiol (2016) 0.75
Food matters: how the microbiome and gut-brain interaction might impact the development and course of anorexia nervosa. Eur Child Adolesc Psychiatry (2017) 0.75
Gut Dysbiosis in Animals Due to Environmental Chemical Exposures. Front Cell Infect Microbiol (2017) 0.75
Biological embedding of childhood adversity: from physiological mechanisms to clinical implications. BMC Med (2017) 0.75
Gut Feelings on Parkinson's and Depression. Cerebrum (2017) 0.75
The microbiome as a novel paradigm in studying stress and mental health. Am Psychol (2017) 0.75
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment. Front Aging Neurosci (2017) 0.75
Neuroendocrine disruption in animal models due to exposure to bisphenol A analogues. Front Neuroendocrinol (2017) 0.75
Primary Pediatric Hypertension: Current Understanding and Emerging Concepts. Curr Hypertens Rep (2017) 0.75
Cross Talk: The Microbiota and Neurodevelopmental Disorders. Front Neurosci (2017) 0.75
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ (1992) 2.64
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry (2012) 2.16
Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry (1992) 1.65
Feeling strained? Influence of genetic background on depression-related behavior in mice: a review. Behav Genet (2006) 1.63
Serotonin receptors, buspirone, and premenstrual syndrome. Lancet (1989) 1.60
Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience (2010) 1.59
Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry (1991) 1.51
Is the carbamazepine-phenelzine combination safe? Am J Psychiatry (1990) 1.38
Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil (2013) 1.25
mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol Psychiatry (2007) 1.24
Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria. Aliment Pharmacol Ther (2012) 1.24
siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry (2005) 1.23
The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil (2010) 1.16
The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) (1998) 1.13
Central serotonergic and noradrenergic receptors in functional dyspepsia. World J Gastroenterol (2006) 1.13
Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther (2011) 1.10
Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry (1997) 1.10
Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. Mol Psychiatry (2011) 1.08
Platelet monoamine oxidase-B activity in alcoholics with lowered dopamine D2 receptor activity. Alcohol Alcohol (1996) 1.07
Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci (1998) 1.05
Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry (2013) 1.03
High-fat diet selectively protects against the effects of chronic social stress in the mouse. Neuroscience (2011) 1.03
Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. BMJ (1992) 1.02
Increased sensitivity to the effects of chronic social defeat stress in an innately anxious mouse strain. Neuroscience (2011) 1.02
Selective serotonin reuptake inhibitors and violence: a review of the available evidence. Acta Psychiatr Scand (2001) 1.02
Depression and anxiety in rheumatoid arthritis: the role of perceived social support. Ir J Med Sci (2006) 1.00
Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome. Neuroscience (2009) 1.00
Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil (2014) 0.99
Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. Neurosci Lett (2012) 0.98
5-HT(2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil (2009) 0.97
Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. J Psychopharmacol (2008) 0.96
Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience (2008) 0.96
Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. Neurogastroenterol Motil (2008) 0.95
Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour. Acta Paediatr (2014) 0.92
Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord (1998) 0.91
Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series. Depress Anxiety (2000) 0.91
Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand (1998) 0.91
Clinical symptomatology and the psychosis risk gene ZNF804A. Schizophr Res (2010) 0.91
BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels? Benef Microbes (2011) 0.88
The psychological impact of arthritis: the effects of illness perception and coping. Ir J Med Sci (2010) 0.88
Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl Psychiatry (2011) 0.88
Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat. Neurogastroenterol Motil (2009) 0.87
Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats. Br J Pharmacol (2012) 0.87
Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia. Ann N Y Acad Sci (1994) 0.86
Differential lipopolysaccharide-induced immune alterations in the hippocampus of two mouse strains: effects of stress. Neuroscience (2012) 0.85
Selective influence of host microbiota on cAMP-mediated ion transport in mouse colon. Neurogastroenterol Motil (2014) 0.85
Age-impaired impulse flow from nucleus basalis to cortex. Nature (1986) 0.84
Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function. Biol Psychiatry (1997) 0.84
Buspirone/prolactin response in post head injury depression. J Affect Disord (1990) 0.84
Role of cholecystokinin and central serotonergic receptors in functional dyspepsia. World J Gastroenterol (2006) 0.83
A distinct subset of submucosal mast cells undergoes hyperplasia following neonatal maternal separation: a role in visceral hypersensitivity? Gut (2009) 0.83
Early-life stress selectively affects gastrointestinal but not behavioral responses in a genetic model of brain-gut axis dysfunction. Neurogastroenterol Motil (2014) 0.83
Nucleus basalis neurons exhibit axonal branching with decreased impulse conduction velocity in rat cerebrocortex. Brain Res (1985) 0.82
Orofacial dyskinesia and the alcohol dependence syndrome. Psychol Med (1992) 0.82
Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery. ACS Chem Neurosci (2012) 0.81
Acute haloperidol increases impulse activity of brain noradrenergic neurons. Brain Res (1984) 0.81
Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation. Neuroscience (2012) 0.80
Platelet MAO activity in subtypes of alcoholics and controls in a homogenous population. J Psychiatr Res (1998) 0.79
Effects of antidepressant treatment on corticotropin-induced cortisol responses in patients with melancholic depression. Psychiatry Res (1997) 0.79
The effects of varying auditory input on schizophrenic hallucinations: a replication. Br J Med Psychol (1994) 0.79
Metyrapone displays antidepressant-like properties in preclinical paradigms. Psychopharmacology (Berl) (1999) 0.79
The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression. J Affect Disord (1999) 0.79
Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology (1999) 0.79
Alpha-2 adrenergic receptor function in post-stroke depression. Psychol Med (1990) 0.79
The physical consequences of depressive illness. BMJ (1999) 0.78
d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity. Am J Psychiatry (1996) 0.78
Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status. Neuroendocrinology (1992) 0.78
Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry (1995) 0.78
A novel role for the metabotropic glutamate receptor-7: modulation of faecal water content and colonic electrolyte transport in the mouse. Br J Pharmacol (2010) 0.78
Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord (1999) 0.78
Neuroleptics decrease calcium-activated potassium conductance in hippocampal pyramidal cells. Brain Res (1987) 0.78
Elevated growth hormone responses to pyridostigmine in obsessive-compulsive disorder: evidence of cholinergic supersensitivity. Am J Psychiatry (1993) 0.78
Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. Br J Psychiatry (1992) 0.77
The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors. Br J Pharmacol (2013) 0.77
Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: effect of reversing primary and secondary face modifications. Eur J Pharm Sci (2012) 0.77
Strain-dependent variations in visceral sensitivity: relationship to stress, anxiety and spinal glutamate transporter expression. Genes Brain Behav (2015) 0.77